share_log

Kintara Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.8%),Lind Global Partners II LLC(5.8%), etc.

Kintara Therapeutics | SC 13G:超过5%持股股东披露文件-Lind Global Fund II LP(5.8%),Lind Global Partners II LLC(5.8%)等

2022/04/20 17:11
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息